Use of Posaconazole for Pulmonary Mucormycosis in Persistent Febrile Neutropenia: A Case Report

Erbay-Apaydin F., Orhan B., Bilgi S., AKALIN E. H.

KLIMIK JOURNAL, vol.24, no.1, pp.57-61, 2011 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 1
  • Publication Date: 2011
  • Doi Number: 10.5152/kd.2011.12
  • Journal Name: KLIMIK JOURNAL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.57-61
  • Bursa Uludag University Affiliated: Yes


Pulmonary mucormycosis is an opportunist fungal infection with high mortality. Posaconazole, an azole antifungal which has a proven efficacy against zygomycetes in vitro, has been shown to be useful as salvage therapy in various studies. We reported herein a lymphoma patient with persistent febrile neutropenia treated for invasive aspergillosis who developed pulmonary mucormycosis subsequently, and shared our experience on his treatment using posaconazole as salvage therapy following amphothericin B, which is thought to enhance survival because of the positive outcome achieved.